CANCER PATIENTS IN NEW SOUTH WALES, AUSTRALIA TO RECEIVE ADVANCED IMAGE GUIDED RADIATION THERAPY TREATMENTS WITH ARRIVAL OF NEW ELEKTA LINEAR ACCELERATORS

CANCER PATIENTS IN NEW SOUTH WALES, AUSTRALIA TO RECEIVE ADVANCED IMAGE GUIDED
RADIATION THERAPY TREATMENTS WITH ARRIVAL OF NEW ELEKTA LINEAR ACCELERATORS

PRESS RELEASE			
Stockholm, July 6, 2007

North Coast Cancer Institute (NCCI) Coffs Harbour and Port Macquarie began
providing radiotherapy treatment services for the first time in the North Coast
region of New South Wales, Australia.

Cancer patients in New South Wales now have access to state-of-the-art
treatments as the latest in image-guided radiation therapy (IGRT) equipment from
Elekta went clinical at both sites. The first treatment was a major step for a
small centre introducing complex treatment technologies such as IMRT and IGRT on
an Elekta Synergy® system advanced digital linear accelerator, supported by
IMPAC MOSAIQ™ Oncology information system. The first patient treated had
intermediate risk prostate cancer and was planned with MRI-CT fusion and
fiducial marker insertion, and treated with dose-escalated 7-field IMRT with
online cone-beam CT and electronic portal image verification.

“As a result of the technology now available at the NCCI, we will be able to
provide patients with the most modern, highest quality radiation oncology
treatment available in Australia,” said Area Director of Cancer Services A.
Prof. Tom Shakespeare. “What's really exciting is seeing this ground-breaking
technology made available to smaller regional centres that have, until now, had
no local access to radiotherapy. Even more impressive, is the fact that our team
has been able to implement complex Intensity Modulated Radiotherapy Treatment
modalities and adopt image guided treatment techniques from the start. This was
accomplished in order to offer patients the highest possible quality of care.
With the incredible support provided by Elekta, Coffs Harbour has evolved from a
city without radiotherapy to a city with the highest quality radiotherapy in the
region and our Port Macquarie centre also will start soon, offering the same
impressive treatment capabilities. It is not surprising that we are now
receiving referrals from across the state and even interstate.”

Elekta Synergy was selected for the NCCI following a competitive tender process
and is considered the market-leading IGRT solution, revolutionizing radiotherapy
by offering integrated 3D volumetric imaging at the time of treatment. By
imaging patients in the treatment position during the actual time of treatment,
Elekta Synergy is able to offer significantly greater treatment accuracy and
higher confidence that the intended therapeutic dose is delivered to the patient
as planned.

About the North Coast Cancer Institute (NCCI)

The NCCI is a newly established Oncology service of the North Coast Area Health
service. It incorporates new radiotherapy facilities at two sites along with
established Medical Oncology services. The NCCI has integrated the radiotherapy
service at two regional sites to promote and maximize quality. The NCCI sites
are making extensive use of the available technology provided by Elekta and
IMPAC to deliver the highest quality care. The Coffs Harbour and Port Macquarie
centres are located in the beautiful North coast region of New South Wales,
Australia.  Each site initially has been established as a single linear
accelerator facility. The two centres provide health care services to a draining
population of 200,000. Please visit www.ncahs.nsw.gov.au and
www.ncahs.nsw.gov.au/ncci-recruitment for more information about the North Coast
Area Health Service and the North Coast Cancer Institute

********

For further information, please contact:

Media inquiries: Michelle Lee, PR and Advertising Manager, Tel: +1 770-670-2447,

e-mail: michelle.lee@elekta.com

Investor inquiries: Okee Williams, Corporate Communications, Elekta AB 
Tel: +46 70 600 53 64 (mobile), e-mail: okee.williams@elekta.com 

About Elekta

Elekta is an international medical-technology Group, providing meaningful
clinical solutions, comprehensive information systems and services for improved
cancer care and management of brain disorders. All of Elekta's solutions employ
non-invasive or minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective. 

Clinical solutions include among others Leksell Gamma Knife® for non-invasive
treatment of brain disorders and Elekta Synergy® for image guided radiation
therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April
2005, the Elekta Group is the world's largest supplier of oncology software. 

Elekta's systems and solutions are used at over 4,000 hospitals around the world
to treat cancer and manage clinical operations as well as to diagnose and treat
brain disorders, including tumors, vascular malformations and functional
disorders.  
With approx. 2,000 employees, Elekta's corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Nordic Exchange under the
ticker EKTAb. For more information about Elekta, please visit www.elekta.com.